The IPO Buzz: Biotech Alumis Joins WEBTOON & LandBridge in Late June IPO Run
The late June run for IPOs picked up some steam early today when Alumis Inc. (ALMS Proposed), a Phase II/III clinical biotech, disclosed terms and launched its $300 million IPO. That launch brings to three the number of large traditional IPOs expected to price this week – the last week of June 20204. WEBTOON Entertainment […]
June 24, 2024 Read More